The isozyme-specific effects of cyclooxygenase-deficiency on bone in mice

Bone

Volumn 39, Issue 5, 2006, Pages 1048-1052

  Myers, L K ^a   Bhattacharya, S D ^a   Herring, P A ^a   Xing, Z ^a   Goorha, S ^b   Smith, R A ^a   Bhattacharya, S K ^a   Carbone, L ^a   Faccio, Roberta ^d   Kang, A H ^a,b   Ballou, L R ^a,b,c  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone mineral density; Cyclooxygenase; Prostaglandins

Indexed keywords

CALCIUM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PARATHYROID HORMONE;

ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE STRENGTH; BONE STRESS; BONE STRUCTURE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME DEFICIENCY; FEMALE; FEMUR; GENE DELETION; MALE; MOUSE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; WILD TYPE;

ANIMALS; BIOMECHANICS; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; CALCIUM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; FEMUR; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; PARATHYROID HORMONE;

EID: 33749534485     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.05.015     Document Type: Article

References (29)

1. Atik O.S., Surat A., and Gogus M.T. Prostaglandin E2-like activity and senile osteoporosis. Prostaglandins Leukot Med 11 (1983) 105-107
2. Bauer D.C., Orwoll E.S., Fox K.M., Vogt T.M., Lane N.E., Hochberg M.C., et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11 (1996) 29-35
3. Brown E.M., and Swartz S.L. Production of prostaglandins by dispersed cells and fragments from bovine parathyroid glands. Prostaglandins 29 (1985) 35-46
4. Carbone L.D., Tylavsky F.A., Cauley J.A., Harris T.B., Lang T.F., Bauer D.C., et al. Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res 18 (2003) 1795-1802
5. Chen Q., Rho J.Y., Fan Z., Laulederkind S.J., and Raghow R. Congenital lack of COX-2 affects mechanical and geometric properties of bone in mice. Calcif Tissue Int 73 (2003) 387-392
6. Jungkeit M.C., and Chole R.A. Ibuprofen inhibits localized bone resorption in the middle ear. Calcif Tissue Int 48 (1991) 267-271
7. Lane N., Coble T., and Kimmel D.B. Effect of naproxen on cancellous bone in ovariectomized rats. J Bone Miner Res 5 (1990) 1029-1035
8. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83 (1995) 483-492
9. Li M., Jee W.S., Ke H.Z., Tang L.Y., Ma Y.F., Liang X.G., et al. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats. J Bone Miner Res 10 (1995) 66-73
10. Maloney C.G., Kutchera W.A., Albertine K.H., McIntyre T.M., Prescott S.M., and Zimmerman G.A. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol 160 (1998) 1402-1410
11. Martel-Pelletier J., Pelletier J.P., and Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 33 (2003) 155-167
12. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83 (1995) 473-482
13. Morton D.J., Barrett-Connor E.L., and Schneider D.L. Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study. J Bone Miner Res 13 (1998) 1924-1931
14. Murakami M., Nakatani Y., Tanioka T., and Kudo I. Prostaglandin E synthase. Prostaglandins Other Lipid Mediat 68-69 (2002) 383-399
15. Myers L.K., Kang A.H., Postlethwaite A.E., Rosloniec E.F., Morham S.G., Shlopov B.V., et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum 43 (2000) 2687-2693
16. Okada Y., Pilbeam C., Raisz L., and Tanaka Y. Role of cyclooxygenase-2 in bone resorption. J UOEH 25 (2003) 185-195
17. Ono K., Akatsu T., Kugai N., Pilbeam C.C., and Raisz L.G. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines. Bone 33 (2003) 798-804
18. Potts J.T. Parathyroid hormone: past and present. J Endocrinol 187 (2005) 311-325
19. Raisz L.G. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 125 (1995) 2024S-2027S
20. Raisz L.G. Physiology and pathophysiology of bone remodeling. Clin Chem 45 (1999) 1353-1358
21. Raisz L.G., Alander C.B., Fall P.M., and Simmons H.A. Effects of prostaglandin F2 alpha on bone formation and resorption in cultured neonatal mouse calvariae: role of prostaglandin E2 production. Endocrinology 126 (1990) 1076-1079
22. Shaftel S.S., Olschowka J.A., Hurley S.D., Moore A.H., and O'Banion M.K. COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res Mol Brain Res 119 (2003) 213-215
23. Simon A.M., Manigrasso M.B., and O'Connor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17 (2002) 963-976
24. Suda T., Udagawa N., Nakamura I., Miyaura C., and Takahashi N. Modulation of osteoclast differentiation by local factors. Bone 17 (1995) 87S-91S
25. Sugiyama T. Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis. J Bone Miner Metab 19 (2001) 89-96
26. Tsuda E., Goto M., Mochizuki S., Yano K., Kobayashi F., Morinaga T., et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234 (1997) 137-142
27. Waters D.J., Caywood D.D., Trachte G.J., Turner R.T., and Hodgson S.F. Immobilization increases bone prostaglandin E. Effect of acetylsalicylic acid on disuse osteoporosis studied in dogs. Acta Orthop Scand 62 (1991) 238-243
28. Xu M., Choudhary S., Goltzman D., Ledgard F., Adams D., Gronowicz G., et al. Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism?. Endocrinology 146 (2005) 1843-1853
29. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., and O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109 (2002) 1405-1415